"le malattie cardiache infiltrative, diagnosi differenziale"

40
La Malattia di Fabry: conoscere per riconoscere 17 giugno 2015, Udine Le malattie cardiache infiltrative, diagnosi differenziale Daniela Miani U.O. Scompenso cardiaco e Trapianti S.O.C. Cardiologia - Dipartimento Cardiotoracico Ospedale Santa Maria della Misericordia di Udine

Upload: centromalattierarefvg

Post on 11-Apr-2017

768 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: "Le malattie cardiache infiltrative, diagnosi differenziale"

La Malattia di Fabry: conoscere per riconoscere17 giugno 2015, Udine

Le malattie cardiache infiltrative, diagnosi differenziale

Daniela MianiU.O. Scompenso cardiaco e Trapianti

S.O.C. Cardiologia - Dipartimento Cardiotoracico Ospedale Santa Maria della Misericordia di Udine

Page 2: "Le malattie cardiache infiltrative, diagnosi differenziale"

Definition• Infiltrative cardiomyopathies are characterized by the

deposition of abnormal substances that cause the ventricular walls to become progressively rigid, thereby impeding ventricular filling

• Some infiltrative cardiac diseases increase ventricular wall thickness (Table 1), while others cause chamber enlargement with secondary wall thinning (Table 2).

• In infiltrative disorder acculation of abnormal substances can be whitin myocytes with hypertrophy or in the myocardialinterstitium without myocyte hypertrophy

Page 3: "Le malattie cardiache infiltrative, diagnosi differenziale"

Physiopathology and Imaging• Infiltrative cardiomyopathy are characterized by

progressive diastolic dysfuncion that anticipate the finalsystolic dysfunction

• Doppler echocardiography assess the diastolic physiology• and atrial remodelling are the hall marks of restrictive

disease• CMR imaging and LGE provide incremental information:• Gadolinium causes magnetic hyperenhancement when

extracellular space is expanded• CMR is used to characterize the type of infiltrative disease

by the location and distribution of LGE.

Page 4: "Le malattie cardiache infiltrative, diagnosi differenziale"

Seward et al 2010 JACC;55:1769–79

Conditions Presenting With Increasaed LV Mass and Thic k Ventricular Walls

Page 5: "Le malattie cardiache infiltrative, diagnosi differenziale"

Seward et al 2010 JACC;55:1769–79

Conditions Presenting With Increasaed LV Mass and Thic k Ventricular Walls

Page 6: "Le malattie cardiache infiltrative, diagnosi differenziale"

Seward et al 2010 JACC;55:1769–79

Conditions With Dilated LV and Infarct Pattern

Page 7: "Le malattie cardiache infiltrative, diagnosi differenziale"

Seward et al 2010 JACC;55:1769–79

Conditions With Dilated LV and Infarct Pattern

Page 8: "Le malattie cardiache infiltrative, diagnosi differenziale"

Hypertrophic cardiomyopathy Hypertensive heart diseas e

Age at Presentation 17–18 yrs Adults

History and ClinicalMaybe asymptomatic, dyspnea,angina, syncope, sudden death History of hypertension

EchocardiographyAsymmetrical hypertrophy,small LV cavity, LVOT obstruction, normal EF

Symmetrical increase in LV wall thickness, mild LV dilation, normal EF

ECG ProfileIncreased QRS complex voltage, pseudo–delta wave, giant T-wave inversion

Increased QRS complex, nonspecific ST-T-wave changes

CMR LGEPatchy, midwall, junctions of the ventricular septum and RV

No pattern, predominantly subendocardial

BiopsyMyocyte hypertrophy, myofibrillar disarray, and interstitial fibrosis

Enlarged myocytes with enlarged or replicated nuclei

Increasaed LV Mass and Thick Ventricular WallsDifferential

Page 9: "Le malattie cardiache infiltrative, diagnosi differenziale"

Ischemic cardiomyopathy Idiopathic dilated cardiomyopathy

Age at Presentation Adult Adult

History and Clinical

Coronary artery disease, congestive heart failure

Congestive heart failure, no known cardiovascular disease

Echocardiography

Dilated LV, regional hypokinesiscorresponding to perfusion territory, decreased systolic function

Dilated LV with global systolic dysfunction

ECG Profile

Multiform premature ventricular complexes, nonsustained ventricular tachycardia

Atrial fibrillation

CMR LGE

Subendocardial, different degrees of transmural extension, corresponds to perfusion territory No LGE, or if present, midwall and patchy

Biopsy

Conditions With Dilated LV and Infarct PatternDifferential

Page 10: "Le malattie cardiache infiltrative, diagnosi differenziale"

Amyloidosis• Systemic amyloidosis is a heterogeneus disorder

characterized by extracellular deposition of 8-10 nm fibrilsoriginate from the misfolding of an altered proteinprecursor in various tissues. The amorphous material iscalled amyloid.

• AL Amyloidosis can occure as primary disorder or secondary to hematologic malingnacy as multiple myeloma, Transthyretin (TTR) amyloidosis, systemicsenile amyloidosis, Systemic secondary amiloidosis

• Amyloid deposition can affect myocardium, valves, coronary vessels.

Page 11: "Le malattie cardiache infiltrative, diagnosi differenziale"

Differential diagnosis (DD)

• DD Is based on ECG , echocardiogram(Doppler) and cardiac RMN and histologicfindings from fat pad aspirate, salivary glands, gingiva and rectal biopsy, endomyocardialbiopsy

• DDIncludes: hypertrophic cardiomyopathy, hypertensive heart disease, infiltrativecardiomyopathy , storage diseases: DanonDisease and Fabry Disease.

Page 12: "Le malattie cardiache infiltrative, diagnosi differenziale"

Low voltage precordial leads on ECG

Page 13: "Le malattie cardiache infiltrative, diagnosi differenziale"

Low voltage precordial leads on ECG

Page 14: "Le malattie cardiache infiltrative, diagnosi differenziale"

Amyloidosis RMN

Page 15: "Le malattie cardiache infiltrative, diagnosi differenziale"

Amyloidosis RMN

Page 16: "Le malattie cardiache infiltrative, diagnosi differenziale"

Amyloidosis

Page 17: "Le malattie cardiache infiltrative, diagnosi differenziale"

Amyloidosis

Page 18: "Le malattie cardiache infiltrative, diagnosi differenziale"

EMB: colorazione Rosso Congo

Page 19: "Le malattie cardiache infiltrative, diagnosi differenziale"

BEM: birifrangenza al Rosso Congo

Page 20: "Le malattie cardiache infiltrative, diagnosi differenziale"

Danon Disease Background

• Danon Disease is a rare X linked dominantskeletal and cardiac muscle disease with mulisystemic clinical manifestations.

• young men present a clincal triade characterizedby skeletal and cardiac myopathy, cardiacconduction abnormalities, arrhythmias, and intelectual impairment

Page 21: "Le malattie cardiache infiltrative, diagnosi differenziale"

Background

• The disease is caused by mutations in LAMP-2 gene (Xq24), encoding for a lysosomal-associated membrane protein The product is involved in the fusion of lysosomes with other membranes and also acts as a receptor for proteins to be imported into lysosomes

• LAMP-2 deficiency leads to pathological glycogen storage in several tissues, such as retinal, hepatic and pulmonary tissue

Page 22: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 23: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 24: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 25: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 26: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 27: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 28: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 29: "Le malattie cardiache infiltrative, diagnosi differenziale"

CM, female 42y

• Symptomatic since 34yrs for palpitations

• Physical examination: normal.

• EKG: normal

• Echo: normal; RMN: normal

• Holter monitoring: BEV >30/h, > 50/h, couplets, NSVT max 6 beats.

• Genetic screening in 2005: LAMP2 +

Page 30: "Le malattie cardiache infiltrative, diagnosi differenziale"

CM, female 42y ECG

Page 31: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 32: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 33: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 34: "Le malattie cardiache infiltrative, diagnosi differenziale"

Sarcoidosis• Sarcoidosis is a multisystemic disease characterizerd by

the formation of granulomas in many tissues.

• Pulmonary involvement with hilar lymphadenopathy is the most frequent presentation

• Secondary skin involvement (erytema nodosus)• Cardiac involvement my be the presenting feature of

sarcoidosis• Cardiac sarcoidosis in autopsy series is present between

20% and 30% of cases

Page 35: "Le malattie cardiache infiltrative, diagnosi differenziale"

Clinical presentation• Dyspnea• Abnormal electrocardiogram• Asymptomatic abnormalities on echocardiography or at

MRI • Dyspnea� DD with dilated cardiomyopathy• Acute sarcoid myocarditis� DD idiopathic giant cell

myocarditis• ECG abnormalities: isolate complete heart block in young

person� DD with Lyme disease• ECG abnormalities: frequent ventricular arrhythmias �DD

with right ventricular cardiomyopathy.

Page 36: "Le malattie cardiache infiltrative, diagnosi differenziale"

Echocardiography, Cardiac MRI• Echo presents regional wall motion abnormalities• Areas of wall thinning in the septum (basal anterior

septum)• Cardiac MRI and PET are more sensitive and specific for

diagnosis• Cardiac MRI demostrates both scar and edema • Acute myocardial inflammation presents focal areas of

tickening and increased signal intensity on T2 weightedimages and early Gadolinium Enhancement in the basaland lateral segments.

Page 37: "Le malattie cardiache infiltrative, diagnosi differenziale"
Page 38: "Le malattie cardiache infiltrative, diagnosi differenziale"

FDG PET demonstrating diffuse, patchy, and intense FDG uptake throughout the left and right ventricular walls

Page 39: "Le malattie cardiache infiltrative, diagnosi differenziale"

Echocardiogram: mitral flow pattern

Page 40: "Le malattie cardiache infiltrative, diagnosi differenziale"

Conclusions

• Infiltrative cardiomyopthies (IF) are relatively raredisorders :

• morphologic characteristics are variable• IF Tend to be misdiagnosed• Clinical suspect, ECG, Echocardiography(Doppler) and Cardiac RMN in congiunction withclinical manifestations are foundamental inestablishing an accurate diagnosis and in theplanning of the appropriate treatment